{1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack [Ultravate X Ointment]

RxCUI: 1301696
RxNorm name: {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack [Ultravate X Ointment]
Display name: ULTRAVATE X OINTMENT (Pack)
Full name: {1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack [Ultravate X Ointment]
Term type: BPCK
Status: Active
Strength: mixed
Dose form: Pack
Route: Pack
Updated: 2026-07-21 06:55:34

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 082012
Active start: 082012
Multiple ingredient: YES
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
lactic acid	100 MG / 1 ML	lactate	lactic acid
halobetasol propionate	0.0005 MG / 1 MG	halobetasol	halobetasol propionate

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Pack	746839

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
lactate	114202
halobetasol	41208

Source Vocabulary Codes#

Code type, Value, Category table
Code type	Value	Category
PRESCRIBABLE	Y	ATTRIBUTES
RXNAV_STR	Ultravate X Ointment Pack	NAMES
RxNorm Name	{1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack [Ultravate X Ointment]	NAMES
RxNorm Synonym	{1 (1.8 OZ) (halobetasol propionate 0.05 % Topical Ointment) / 1 (8 OZ) (lactic acid 10 % Topical Cream) } Pack [Ultravate X Ointment]	NAMES
RxNorm Synonym	Ultravate X Ointment Pack	NAMES
TTY	BPCK	ATTRIBUTES
RxCUI	1301696	CODES
MMSL_CODE	BD27814	CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11	Source	Active
10631011901	rxnav_ndcs	yes

DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
21e4e0c0-18c7-480a-af4e-7b553fe8b68c	ULTRAVATE X (halobetasol propionate ointment) Ointment, 0.05% For Dermatological Use Only. Not for Ophthalmic Use. Rx only	Ranbaxy Laboratories Inc. \| Contract Pharmaceuticals Limited \| CA-BOTANA INTERNATIONAL	20121108

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	D07AC	Corticosteroids, potent (group III)	ATC1-4		halobetasol
ATC	G01AD	Organic acids	ATC1-4		lactic acid
FDASPL	N0000175576	Corticosteroid	EPC	has_epc	halobetasol
FDASPL	N0000175833	Acidifying Activity	MOA	has_moa	lactic acid
FDASPL	N0000175450	Corticosteroid Hormone Receptor Agonists	MOA	has_moa	halobetasol
MEDRT	D002990	Clobetasol	CHEM	has_ingredient	halobetasol propionate
MEDRT	D002990	Clobetasol	CHEM	has_ingredient	halobetasol
MEDRT	D019344	Lactic Acid	CHEM	has_ingredient	lactic acid
MEDRT	D019344	Lactic Acid	CHEM	has_ingredient	lactate
MEDRT	D003872	Dermatitis	DISEASE	may_prevent	lactic acid
MEDRT	D003872	Dermatitis	DISEASE	may_treat	lactic acid
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	lactic acid
MEDRT	D005148	Facial Dermatoses	DISEASE	may_treat	halobetasol propionate
MEDRT	D005148	Facial Dermatoses	DISEASE	may_treat	lactic acid
MEDRT	D005148	Facial Dermatoses	DISEASE	may_treat	halobetasol
MEDRT	D005533	Foot Dermatoses	DISEASE	may_treat	halobetasol propionate
MEDRT	D005533	Foot Dermatoses	DISEASE	may_treat	halobetasol
MEDRT	D006229	Hand Dermatoses	DISEASE	may_treat	halobetasol
MEDRT	D006229	Hand Dermatoses	DISEASE	may_treat	halobetasol propionate
MEDRT	D006967	Hypersensitivity	DISEASE	ci_with	halobetasol
MEDRT	D006967	Hypersensitivity	DISEASE	ci_with	halobetasol propionate
MEDRT	D007249	Inflammation	DISEASE	may_treat	halobetasol
MEDRT	D007249	Inflammation	DISEASE	may_treat	halobetasol propionate
MEDRT	D007868	Leg Dermatoses	DISEASE	may_treat	halobetasol
MEDRT	D007868	Leg Dermatoses	DISEASE	may_treat	halobetasol propionate
MEDRT	D011537	Pruritus	DISEASE	may_treat	halobetasol propionate
MEDRT	D011537	Pruritus	DISEASE	may_treat	halobetasol
MEDRT	D012536	Scalp Dermatoses	DISEASE	may_treat	halobetasol
MEDRT	D012536	Scalp Dermatoses	DISEASE	may_treat	halobetasol propionate
MEDRT	N0000000159	Glucocorticoid Receptor Agonists	MOA	has_moa	halobetasol propionate
MEDRT	N0000000159	Glucocorticoid Receptor Agonists	MOA	has_moa	halobetasol
MEDRT	N0000000134	Lipoxygenase Inhibitors	MOA	has_moa	halobetasol
MEDRT	N0000000134	Lipoxygenase Inhibitors	MOA	has_moa	halobetasol propionate
MEDRT	N0000009915	Unknown Cellular or Molecular Interaction	MOA	has_moa	lactic acid
MEDRT	N0000008297	Antipruritic Activity	PE	has_pe	halobetasol
MEDRT	N0000008297	Antipruritic Activity	PE	has_pe	halobetasol propionate
MEDRT	N0000008663	Decreased Immunologically Active Molecule Activity	PE	has_pe	halobetasol
MEDRT	N0000008663	Decreased Immunologically Active Molecule Activity	PE	has_pe	halobetasol propionate
MEDRT	N0000008841	Decreased Protein Synthesis	PE	has_pe	halobetasol
MEDRT	N0000008841	Decreased Protein Synthesis	PE	has_pe	halobetasol propionate
MEDRT	N0000009735	Decreased Skin Keratinization	PE	has_pe	lactic acid
MEDRT	N0000009035	Emollient Activity	PE	has_pe	lactic acid
MEDRT	N0000009908	Vasoconstriction	PE	has_pe	halobetasol
MEDRT	N0000009908	Vasoconstriction	PE	has_pe	halobetasol propionate

Group, Type, Concept table
Group	Type	Concept	Source
BPCK	BPCK	{1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack [Ultravate X Ointment]	rxnav_allrelated
DF	DF	Pack	rxnav_allrelated
DFG	DFG	Topical Product	rxnav_allrelated
GPCK	GPCK	{1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack	rxnav_allrelated
IN	IN	halobetasol	rxnav_allrelated
IN	IN	lactate	rxnav_allrelated
PIN	PIN	halobetasol propionate	rxnav_allrelated
PIN	PIN	lactic acid	rxnav_allrelated
SCD	SCD	halobetasol propionate 0.0005 MG/MG Topical Ointment	rxnav_allrelated
SCD	SCD	lactic acid 100 MG/ML Topical Cream	rxnav_allrelated
SCDC	SCDC	halobetasol propionate 0.0005 MG/MG	rxnav_allrelated
SCDC	SCDC	lactic acid 100 MG/ML	rxnav_allrelated
SCDF	SCDF	halobetasol Topical Ointment	rxnav_allrelated
SCDF	SCDF	lactate Topical Cream	rxnav_allrelated
SCDFP	SCDFP	halobetasol propionate Topical Ointment	rxnav_allrelated
SCDFP	SCDFP	lactic acid Topical Cream	rxnav_allrelated
SCDG	SCDG	halobetasol Topical Product	rxnav_allrelated
SCDG	SCDG	lactate Topical Product	rxnav_allrelated
SCDGP	SCDGP	halobetasol propionate Topical Product	rxnav_allrelated
SCDGP	SCDGP	lactic acid Topical Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	GENERAL_CARDINALITY	SINGLE
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	PRESCRIBABLE	Y
ATTRIBUTES	TTY	BPCK
CODES	MMSL_CODE	BD27814
CODES	RxCUI	1301696
NAMES	Prescribable Synonym	Ultravate X Topical Ointment Pack
NAMES	RXNAV_STR	Ultravate X Ointment Pack
NAMES	RxNorm Name	{1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack [Ultravate X Ointment]
NAMES	RxNorm Synonym	{1 (1.8 OZ) (halobetasol propionate 0.05 % Topical Ointment) / 1 (8 OZ) (lactic acid 10 % Topical Cream) } Pack [Ultravate X Ointment]
NAMES	RxNorm Synonym	Ultravate X Ointment Pack
SOURCES	Source	Micromedex RED BOOK

{1 (50000 MG) (halobetasol propionate 0.0005 MG/MG Topical Ointment) / 1 (225000 MG) (lactic acid 100 MG/ML Topical Cream) } Pack [Ultravate X Ointment]

RxNorm Status History#

Ingredients And Strength#

Dose Form Concepts#

Derived Ingredient Concepts#

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

DailyMed Labels#

Drug Classes#

Related Concepts#

Properties#